Get startedLog in
    Picture of BioPlus Acquisition logo

    BIOSU — BioPlus Acquisition Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    FinancialsAdventurousSmall Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for BioPlus Acquisition, fiscal year end - December 31st, millions except per share.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    Period Length:—12 M12 M
    Source:10-K10-K
    Standards:—
    USG
    USG
    Status:
    fx
    Preliminary    		FinalFinal
    Net Income/Starting Line—-0.142
    Non-Cash Items—-0.009-3.17
    Other Non-Cash Items
    Changes in Working Capital—-0.6250.48
    Change in Prepaid Expenses
    Change in Accrued Expenses
    Cash from Operating Activities—-0.774-0.691
    Other Investing Cash Flow Items—-2350
    Other Investing Cash Flow
    Cash from Investing Activities—-2350
    Financing Cash Flow Items—225-0.068
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities—2360.196
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash—0.636-0.495